Non-Vitamin K Antagonist Oral Anticoagulants and the Treatment of Venous Thromboembolism in Cancer Patients: A Semi Systematic Review and Meta-Analysis of Safety and Efficacy Outcomes-Reference-Cited by-同舟云学术

Non-Vitamin K Antagonist Oral Anticoagulants and the Treatment of Venous Thromboembolism in Cancer Patients: A Semi Systematic Review and Meta-Analysis of Safety and Efficacy Outcomes

Published:2014-12-05 Issue:12 Volume:9 Page:e114445
ISSN:1932-6203
Container-title:PLoS ONE
language:en
Short-container-title:PLoS ONE

Author:

Larsen Torben Bjerregaard,Nielsen Peter Brønnum,Skjøth Flemming,Rasmussen Lars Hvilsted,Lip Gregory Y. H.

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference32 articles.

1. Pulmonary embolism and thrombophlebitis in the United States, 1970–1985;RF Gillum;Am Heart J,1987

2. Estimated annual numbers of US acute-care hospital patients at risk for venous thromboembolism;FA Anderson;Am J Hematol,2007

3. Venous thromboembolism (VTE) in Europe. The number of VTE events and associated morbidity and mortality;AT Cohen;Thromb Haemost,2007

4. Recurrent venous thromboembolism and bleeding complications during anticoagulant treatment in patients with cancer and venous thrombosis;P Prandoni;Blood,2002

5. The long-term clinical course of acute deep venous thrombosis;P Prandoni;Ann Intern Med,1996

Cited by 55 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Real-world data emulating randomized controlled trials of non-vitamin K antagonist oral anticoagulants in patients with venous thromboembolism;BMC Medicine;2023-09-29

2. Emergence of swine influenza A virus, porcine respirovirus 1 and swine orthopneumovirus in porcine respiratory disease in Germany;Emerging Microbes & Infections;2023-08-02

3. Direct-Acting Oral Anticoagulant Therapy in Cancer Patients—A Review;Cancers;2023-05-10

4. Systematic Review and Meta-Analysis of Oral Anticoagulant Therapy in Atrial Fibrillation Cancer Patients;Cancers;2023-04-30

5. The Efficacy of Low Dose Edoxaban for the Treatment of Venous Thromboembolism;The Japanese Journal of Phlebology;2022-02-17